Maciej Mazurec
7PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Apr 14, 2026
Informative High-Risk HPV Genotyping in Cervical Cancer Screening: Integrated Analysis of Cytology and p16/Ki67 Dual Staining.Martyna Trzeszcz, Karolina Mazurec, Maciej Mazurec
|Oct 16, 2024
Distribution of 14 High-Risk HPV Types and p16/Ki67 Dual-Stain Status in Post-Colposcopy Histology Results: Negative, Low- and High-Grade Cervical Squamous Intraepithelial Lesions.Karolina Mazurec, Martyna Trzeszcz, Maciej Mazurec
|Mar 05, 2024
Should we use risk selection tests for HPV 16 and/or 18 positive cases: Comparison of p16/Ki67 and cytology.Karolina Mazurec, Martyna Trzeszcz, Maciej Mazurec
|Nov 27, 2023
p16/Ki67 dual stain triage versus cytology in primary human papillomavirus-based cervical cancer screening with limited genotyping.Martyna Trzeszcz, Maciej Mazurec, Robert Jach
|Oct 28, 2023
Triage Strategies for Non-16/Non-18 HPV-Positive Women in Primary HPV-Based Cervical Cancer Screening: p16/Ki67 Dual Stain vs. Cytology.Karolina Mazurec, Martyna Trzeszcz, Maciej Mazurec
|Nov 27, 2021
Is Primary HPV with Secondary p16/Ki67 Dual-Stain an Alternative HSIL-Risk Detection Strategy in Cervical Cancer Screening for Women under 30 Years?Martyna Trzeszcz, Maciej Mazurec, Robert Jach
Pageof 2
